Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Publisher’s ASCO Spotlight: Compare Your Insights To Oncologists'

Executive Summary

Inspired by next week’s ASCO conference, Informa is crowdsourcing insights from cancer experts, including their predictions on cancer prescribing patterns, trial outcomes and advances in new types of oncology treatments. Scrip readers are invited to participate.

Scrip publisher Informa is currently experimenting with ways to tap into expert wisdom on biopharma R&D, treatment practice, and clinical and market outcomes, particularly in rapidly evolving major treatment areas. One key pilot will use a crowdsourcing methodology to obtain consensus predictions in the oncology field, with an eye to the American Society of Clinical Oncology’s annual meeting in Chicago. We invite Scrip readers to provide the wider biopharma industry perspective by participating.  Participants will have access to the results of the physician and Scrip reader predictions.

Learn More

If you would like to participate in an online panel, to be conducted next week, or if you would simply like to know more about the approach and the results, please register here.

The crowdsourcing specialists will ask a series of questions to a panel of practicing oncologists from Informa’s Skipta physician network.  Skipta is the leading social network of specialized online  medical communities and includes more than half of US oncologists.  MEDiSTRAVA, an information strategy consulting group, is collaborating on the project, and will also provide oncology experts to join Informa oncology experts to make up a second panel.  The third panel will be Scrip readers.  The goal is to compare predictions among oncologists, Informa/MEDiSTRAVA analysts, and Scrip survey participants.

The questions will address topics including prescribing patterns of specific drugs, efficacy of new treatment approaches, effects of diagnostics, and clinical trial results. It will also include a few descriptive questions aimed more at understanding collective insight than predictive opinions of experts; for example, what factors influence oncologists’ decisions to consider newly available options in the clinic. We will share some of the results in upcoming Scrip articles. Stay tuned for more!

Go here if you’re interested in participating.
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC125303

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel